/
SEER
$2.13-$0.04 (-1.87%)live
Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
1
institution
Market cap
$118.5M
55M shares
52-week range
$1.55 – $2.41
68% from low
Sector
LABORATORY ANALYTICAL INSTRUMENTS
Exchange
NASDAQ
CS
Change$-28.33
Seer, Inc. Class A Common Stock
Seer Inc is a life sciences company, develops and commercializes products to decode the biology of the proteome. The company offers Proteograph Product Suite, an integrated solution that includes proprietary engineered nanoparticles, consumables, automation instrumentation, and data analysis software to perform proteomic analysis to provide a solution that can be incorporated by nearly any lab for research use only. It markets and sells its products for research use only, which cover academic institutions, life sciences, and research laboratories, as well as biopharmaceutical and biotechnology companies for non-diagnostic and non-clinical purposes. The company operates in China, Australia, Eastern Europe, Israel, Japan and South Africa.
www.seer.bio- Employees
- 124
- IPO / List date
- Dec 4, 2020
- HQ
- REDWOOD CITY, CA
Held by traders on TradeandTell
No one on the platform currently holds SEER.
Super investors & insiders
Institutions holding (13F)
| Institution | Shares | Reported |
|---|---|---|
| Renaissance Technologiesas of 2026-03-31 | 976,688 | $1.6M |
Insider activity (SEC Form 4)
Recent trades on TradeandTell
No one on the platform has traded SEER yet.
